Factors affecting 30-day postoperative complications after emergency surgery during the COVID-19 outbreak: A multicentre cohort study
Ellen de Bock(University Medical Center Utrecht), Milan C. Richir(Utrecht University), Joost T. Heikens(Elisabeth-TweeSteden Ziekenhuis), Djamila Boerma(St. Antonius Ziekenhuis), Mando D. Filipe(University Medical Center Utrecht), Paul M. Verheijen(Meander Medisch Centrum), Apollo Pronk(Diakonessenhuis hospital), Menno R. Vriens(University Medical Center Utrecht)
Cited by 4
Related Papers
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
|The Lancet Oncology|2018|582
The Dutch Surgical Colorectal Audit
|European Journal of Surgical Oncology|2013|362
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326
Long-term Outcome After Laparoscopic Ventral Mesh Rectopexy
|Annals of Surgery|2015|198